🇺🇸 FDA
Patent

US 12269858

Activin receptor type IIB variants and methods of use thereof

granted A61KA61K38/00A61K38/1709

Quick answer

US patent 12269858 (Activin receptor type IIB variants and methods of use thereof) held by Keros Therapeutics, Inc. expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Keros Therapeutics, Inc.
Grant date
Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/00, A61K38/1709, A61K38/179, A61P